In the case of MYC, almost 92% of PCa patients with amplified YWHAZ presented MYC alterations as opposed to only 1.8% of patients with no YWHAZ alteration in TCGA-PRAD. The gene discussed is YWHAZ; the disease is posterior cortical atrophy.